Press Releases

Home > Press Releases

Press Releases (Page 138)

MEDIROM Rehab Solutions Inc. Acquires Rehabilitation Centers from Y’s, Inc.

TOKYO, Oct. 07, 2024 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM) (“Medirom” or the “Company”) is pleased to announce that it is capitalizing on its extensive experience operating wellness clinics and healthcare technology to expand into the rehabilitation industry. In doing so, MEDIROM established a wholly-owned subsidiary, MEDIROM Rehab Solutions Inc., which acquired all of the rehabilitation centers of... ❯❯❯

Extendicare Announces Timing of 2024 Third Quarter Results and Conference Call

MARKHAM, Ontario, Oct. 04, 2024 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced today that it plans to release its financial results for the third quarter of 2024 after market close on Tuesday, November 12, 2024. A conference call hosted by Michael Guerriere, President and Chief Executive Officer, and David Bacon, Senior Vice President and Chief Financial Officer, will be held on Wednesday,... ❯❯❯

Wake Radiology Celebrates Opening of Expanded, Patient-Centered, State-Of-The-Art Cary Breast Center

Raleigh, N.C., Oct. 03, 2024 (GLOBE NEWSWIRE) -- Wake Radiology’s newly expanded, state-of-the-art Cary Breast Center is open and providing comprehensive breast imaging services in one easily accessible location: 300 Ashville Avenue, Cary. “As the long-time imaging leader in the Triangle, Wake Radiology is excited to welcome patients to our newly expanded Cary Breast Center, which focuses exclusively on specialized breast... ❯❯❯

Allarity Therapeutics Strengthens Leadership with Key Appointments to Accelerate Stenoparib PARP Inhibitor Program

Former Eli Lilly Research Fellow Jeremy R. Graff, Ph.D., appointed as President and Chief Development Officer to lead the Company’s clinical development programsEli Lilly and Celgene veteran Jose Iglesias, M.D., joins as Consultant Chief Medical Officer to drive the stenoparib program toward regulatory approvalFormer President of Novo Nordisk’s U.S. Operations, Jesper Høiland, appointed as Strategic Advisor to guide strategic initiative... ❯❯❯

The Pennant Group Announces Pricing of Public Offering of Common Stock

EAGLE, Idaho, Oct. 02, 2024 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG) (the “Company”) today announced the pricing of an underwritten public offering of 3,500,000 shares of its common stock at a public offering price of $31.00 per share. The gross proceeds from the offering, before deducting underwriting discounts and commissions and offering expenses, are expected to be $108.5 million. In addition, the Company has... ❯❯❯

Sienna Announces Third Quarter 2024 Results Release Date and Conference Call

MARKHAM, Ontario, Oct. 01, 2024 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“Sienna” or the “Company”) (TSX: SIA) announced that it will report its 2024 third quarter results after market close on Monday, November 11, 2024. Nitin Jain, President and Chief Executive Officer, and David Hung, Executive Vice President and Chief Financial Officer, will host a conference call for the investment community the following day, Tuesday,... ❯❯❯

Wake Radiology Launches ‘We See the Difference’ Campaign for Breast Cancer Awareness Month

Raleigh, N.C., Oct. 01, 2024 (GLOBE NEWSWIRE) -- In recognition of Breast Cancer Awareness Month, Wake Radiology is launching a month-long campaign during October to highlight the importance of early breast cancer detection and prevention.  Wake Radiology’s “We See The Difference” campaign (image attached) underscores the life-saving potential of early detection. As part of the “We See The Difference” campaign, Wake Radiology... ❯❯❯

Yalda Olcott, PharmD, Joins Noom as Head of Healthcare and Pharmacy Operations

Noom Appoints Olcott to Advance Noom Med Programming Following Newly Launched GLP-1Rx Solution NEW YORK, Oct. 01, 2024 (GLOBE NEWSWIRE) -- Noom, the leading digital healthcare company committed to chronic disease prevention and empowering people to live better longer, is pleased to announce the appointment of Yalda Olcott, PharmD, as Head of Healthcare and Pharmacy Operations. Reporting to Noom’s Chief Medical Officer, Dr. Adonis... ❯❯❯

Canadian Dermatology Association (CDA) Announces 2025 Shade Structure Grant Recipients

OTTAWA, Oct. 01, 2024 (GLOBE NEWSWIRE) -- The Canadian Dermatology Association is proud to announce the recipients of the 2025 CDA Shade Structure Grant Program. This year's grants, aimed at helping public schools, child care centres, city parks, and non-profit organizations create sun-safe environments in their communities, will benefit six outstanding projects across the country. The following organizations and projects have been... ❯❯❯

The Pennant Group Announces Public Offering of Common Stock

EAGLE, Idaho, Sept. 30, 2024 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG) (the “Company”) today announced that it has commenced an underwritten public offering of 3,500,000 shares of common stock of the Company. The Company intends to grant the underwriters a 30-day option to purchase up to 525,000 additional shares of common stock. The Company expects to use the net proceeds from the offering to repay outstanding... ❯❯❯